Background: Clinical trial designs have historically been biased towards the Caucasian population, with limited ...

The "Oncolytic Virus Immunotherapy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Oncolytic Virus Immunotherapy was valued at US$156.8 ...

Within weeks of treating patients with CER-1236, the company hopes to start learning about its safety profile and gauge efficacy markers.

(NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted ...

Growth is fueled by advancements in molecular virology and gene editing, revitalizing oncolytic viruses as key cancer ...

Neurizon Therapeutics is working to develop a potentially effective treatment for the most common form of MND.

Investor capital is pouring into AI-driven healthcare, with Pittsburgh-based Abridge AI Inc. pulling in $300 million at a ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to the Oral Abstract Session: Genitourinary Cancer—Prostate, Testicular, and Penile.

OncoPilot is a promptable AI that claims to measure solid tumours in 3D with radiologist-level accuracy, in real time.

The Rare Inflammatory Disease Treatment Market has garnered a market value of USD 12,664 Million in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022 to 2028 and reach ...

The lab brings together patients, therapists, engineers and designers to come up with products and services to improve ...